Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director | June 11, 2020 | June 15, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date June 11, 2020 · Filed June 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,095 |
Ending reported balance
After 2020-06-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-06-11 · Sale · Disposed 3,000 · Balance 11,895 Row 2 · 2020-06-12 · Sale · Disposed 2,800 · Balance 9,095 Row 3 · 2020-06-15 · Sale · Disposed 4,000 · Balance 5,095 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2020 Filed Jun 15, 2020 17:44 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 4,000 | $52.55 | $210,188.00 |
DisclosureSEC source: 0001209191-20-036712 · doc4.xml · nonDerivative · entry 3 AKERS THOMAS CLARK · CIK 0001105718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,095 Read SEC document |
| June 12, 2020 Filed Jun 15, 2020 17:44 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 2,800 | $52.78 | $147,792.12 |
DisclosureSEC source: 0001209191-20-036712 · doc4.xml · nonDerivative · entry 2 AKERS THOMAS CLARK · CIK 0001105718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,095 Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 17:44 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 3,000 | $53.74 | $161,232.90 |
DisclosureSEC source: 0001209191-20-036712 · doc4.xml · nonDerivative · entry 1 AKERS THOMAS CLARK · CIK 0001105718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,895 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:46 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045183 · doc4.xml · nonDerivative · entry 1 AKERS THOMAS CLARK · CIK 0001105718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,895 F1 · shares: The restricted stock vests in full on the earlier of (i) August 6, 2020 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 17:31 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 3,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045876 · doc4.xml · nonDerivative · entry 1 AKERS THOMAS CLARK · CIK 0001105718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,801 F1 · shares: The restricted stock vests in full on the earlier of (i) August 7, 2019 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 20:31 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 2,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047799 · doc4.xml · nonDerivative · entry 1 AKERS THOMAS CLARK · CIK 0001105718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,750 F1 · shares: The restricted stock vests in full on the earlier of (i) August 3, 2018 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.